Works matching AU Quattrini, Luca


Results: 7
    1
    2

    Aldose reductase inhibitors: 2013-present.

    Published in:
    Expert Opinion on Therapeutic Patents, 2019, v. 29, n. 3, p. 199, doi. 10.1080/13543776.2019.1582646
    By:
    • Quattrini, Luca;
    • La Motta, Concettina
    Publication type:
    Article
    3
    4

    Soyasaponins from Zolfino bean as aldose reductase differential inhibitors.

    Published in:
    Journal of Enzyme Inhibition & Medicinal Chemistry, 2019, v. 34, n. 1, p. 350, doi. 10.1080/14756366.2018.1553166
    By:
    • Balestri, Francesco;
    • De Leo, Marinella;
    • Sorce, Carlo;
    • Cappiello, Mario;
    • Quattrini, Luca;
    • Moschini, Roberta;
    • Pineschi, Carlotta;
    • Braca, Alessandra;
    • La Motta, Concettina;
    • Da Settimo, Federico;
    • Del-Corso, Antonella;
    • Mura, Umberto
    Publication type:
    Article
    5

    Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation.

    Published in:
    International Journal of Molecular Sciences, 2021, v. 22, n. 12, p. 6325, doi. 10.3390/ijms22126325
    By:
    • Antonioli, Luca;
    • Pellegrini, Carolina;
    • Fornai, Matteo;
    • Benvenuti, Laura;
    • D'Antongiovanni, Vanessa;
    • Colucci, Rocchina;
    • Bertani, Lorenzo;
    • Di Salvo, Clelia;
    • Semeghini, Giorgia;
    • La Motta, Concettina;
    • Giusti, Laura;
    • Zallocco, Lorenzo;
    • Ronci, Maurizio;
    • Quattrini, Luca;
    • Angelucci, Francesco;
    • Coviello, Vito;
    • Oh, Won-Keun;
    • Ha, Quy Thi Kim;
    • Németh, Zoltan H.;
    • Haskó, Gyorgy
    Publication type:
    Article
    6
    7